197 related articles for article (PubMed ID: 10522061)
21. Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer.
Saikawa Y; Kubota T; Kumagai K; Nakamura R; Kumai K; Shigematsu N; Kubo A; Kitajima M; Kitagawa Y
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):173-9. PubMed ID: 17996385
[TBL] [Abstract][Full Text] [Related]
22. [Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer].
Saji S; Toge T; Kurosu Y; Hirata K; Gochi A; Tominaga S; Inokuchi K
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2499-507. PubMed ID: 12506472
[TBL] [Abstract][Full Text] [Related]
23. [A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Yamada T; Watanabe A; Sadou S; Nishinuma T; Tsurui H; Watanabe T; Nakano H
Gan To Kagaku Ryoho; 2000 Feb; 27(2):281-4. PubMed ID: 10700901
[TBL] [Abstract][Full Text] [Related]
24. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
[TBL] [Abstract][Full Text] [Related]
25. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
26. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Kiyohashi A; Kurihara M; Yoshida S; Ohkubo T; Suga S
Jpn J Clin Oncol; 1993 Feb; 23(1):41-5. PubMed ID: 8459640
[TBL] [Abstract][Full Text] [Related]
29. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
30. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
32. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
33. [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Kagawa R; Nakayama N; Yamaguchi T; Sakata S; Tada M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1989-94. PubMed ID: 12465402
[TBL] [Abstract][Full Text] [Related]
34. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
[TBL] [Abstract][Full Text] [Related]
35. [Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
Takagi T; Ueda N; Kanemoto H
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1453-6. PubMed ID: 16227747
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between prolonged life span and changes of serum IAP and albumin induced by the therapy of lentinan plus tegafur in inoperable and recurrent gastric cancer].
Ishigami H; Ogawa K; Fujimoro S; Okui K
Nihon Geka Gakkai Zasshi; 1992 Aug; 93(8):800-4. PubMed ID: 1435705
[TBL] [Abstract][Full Text] [Related]
37. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
[TBL] [Abstract][Full Text] [Related]
38. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
